Scopul nostru este sprijinirea şi promovarea cercetării ştiinţifice şi facilitarea comunicării între cercetătorii români din întreaga lume.
Autori: M. Ranetti, M Ionescu, Lavinia Hinescu, E Ionicã, V. Anuta, A. Ranetti, C Stecoza, C Mircioiu
Editorial: Farmacia, ISI - SCIENCE CITATION INDEX EXPANDED, ISSN: 0014-8237, Vol. 57(6), p.728-735, 2009.
The study presents the development and validation of a simple HPLC method for the simultaneous determination of metformin (MTF) and gliclazide (GCZ) in the presence of glibenclamide, in human plasma, for the clinical monitoring of MTF and GCZ after oral administration or for bioequivalence studies.
Ion-pair separation followed by UV detection performed on deproteinised plasma samples was chosen for the determination of metformin and gliclazide. The internal standard was glybenclamide. The HPLC method used a Zorbax Eclipse XDB-C18 150×4.6 mm i.d. (5μm) column and analytical guard column 12.5×4.6 mm (5μm), with a gradient elution (1 mL/min) at 40°C column temperature. The mobile phase was acetonitrile:
methanol (1:1v/v) and sodium dodecylsulphate 5mM, pH=3.5 with H3PO4 85% and gradient elution. The eluent was monitored at 236 nm.
The calibration curve was linear within the range of 0.05-5.00 μg/mL (r2=0.99, n=6). The lowest limit of quantification (LLOQ) was 50 ng/mL for metformin and 49 ng/mL for gliclazide.
The proposed method was validated and proved to be adequate for metformin and gliclazide clinical monitoring, bioavailability and bioequivalence studies.
Cuvinte cheie: HPLC, Metformin, Gliclazide